Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05962034 · ClinicalTrials.gov registry record · Phase 4
Thromboxane Function in Women With Endometriosis
A Phase 4 study of Endometriosis, sponsored by Penn State University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT05962034: Recruiting Phase 4 study of Endometriosis, sponsored by Penn State University.
NCT05962034 is a Phase 4 study of Endometriosis that is actively recruiting participants, run by Penn State University. The registered enrollment target is 96 participants, below the 262-participant average among 48 other Endometriosis trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05962034, a Phase 4 study of Endometriosis, is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare neurovascular regulation in women with endometriosis and healthy women. The main questions it aims to answer are: * Do women with endometriosis have greater blood pressure and pain responses to a stimulus than healthy women? * Do women with endometriosis have greater platelet activity than healthy women? Participants will take aspirin and/or placebo and will: * perform hand grip exercise and cold pressor tests * undergo iontophoresis and blood draw Researchers will compare women with and without endometriosis to see if there is a difference in neurovascular regulation.
Primary Outcome
change in blood pressure from baseline to maximum
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Aspirin
Study Locations (1)
Pennsylvania
- Noll Laboratory - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2027-08-01 |
| Phase | Phase 4 |
What NCT05962034 shows while recruiting
NCT05962034 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 262-participant average among 48 other Endometriosis trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05962034 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05962034 about?
NCT05962034 is a clinical study titled "Thromboxane Function in Women With Endometriosis". The goal of this clinical trial is to compare neurovascular regulation in women with endometriosis and healthy women. The main questions it aims to answer are: * Do women with endometriosis have greater blood pressure and pain responses to a stimulus than healthy women? * Do women with endometriosi...
What is the current status of trial NCT05962034?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 96 participants. The study started on 2024-01-01. Estimated completion is 2027-08-01.
What conditions does trial NCT05962034 study?
This clinical trial studies the following conditions: Endometriosis.
What interventions are being tested in trial NCT05962034?
The interventions under investigation include: Placebo (OTHER), Aspirin (DRUG).
Who is sponsoring clinical trial NCT05962034?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05962034 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05962034's enrollment target sits among peer trials
96 26th of 48 higher than 23 of 48 other Endometriosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometriosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis
RECRUITING · Phase 4
-
Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee
RECRUITING · Phase 4
-
The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery
ACTIVE NOT RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Supplementation in Adolescent Girls With Endometriosis
COMPLETED · Phase 4
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI